A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC
Clinical trial NCT05670106 · COMPLETED
Trial details
- NCT number
- NCT05670106
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-16
- Primary completion
- 2024-05-17
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.